BHQ-880

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameBHQ-880
Drug Alias NameAnti-DKK1 mAbAnti-DKKK-1 neutralising antibodyMOR-4910BHQ-880
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionDickkopf-related protein 1 inhibitors
TargetsDickkopf-related protein 1
Therapy Area/IndicationsRenal InsufficiencySmoldering Multiple MyelomaMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanyUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMorphosys AgNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsRenal InsufficiencySmoldering Multiple MyelomaMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A